SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-141066
Filing Date
2024-05-17
Accepted
2024-05-17 06:05:03
Documents
19
Period of Report
2024-05-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d815150d8k.htm   iXBRL 8-K 30413
2 EX-1.1 d815150dex11.htm EX-1.1 208106
3 EX-5.1 d815150dex51.htm EX-5.1 13553
4 EX-99.1 d815150dex991.htm EX-99.1 7733
8 GRAPHIC g815150g0517071700576.jpg GRAPHIC 1690
9 GRAPHIC g815150g0517073029503.jpg GRAPHIC 5747
10 GRAPHIC g815150g0517073029863.jpg GRAPHIC 2373
  Complete submission text file 0001193125-24-141066.txt   467909

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA eras-20240516.xsd EX-101.SCH 2835
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE eras-20240516_lab.xml EX-101.LAB 18737
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eras-20240516_pre.xml EX-101.PRE 11697
22 EXTRACTED XBRL INSTANCE DOCUMENT d815150d8k_htm.xml XML 3759
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 24957615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)